Medivation shareholders should be ‘thrilled’ about price of Pfizer deal: analysts
August 22, 2016 at 12:46 PM EDT
Medivation investors should be “thrilled” that Pfizer agreed to pay what it did to buy the biotechnology company, with the stock trading nearly 20% above its previous record closing price.
